Considering that pro-inflammatory cytokines have been widely described as mediators of immobile and anhedonic behavior in TST, FST, and SPT, we concluded that administration of BLLL could attenuate CUS-induced depression-like behavior in mice in part by suppressing neuroinflammation that accompanied the restoration of BDNF expression. The gene discussed is BDNF; the disease is major depressive disorder.